Citation

Joan X. Hu, Stephen W. Lagakos. Nonparametric estimation of the mean function of a stochastic process with missing observations. Lifetime Data Analysis. 2007. 13: 51-73.

Citation

Rui Wang, Stephen W. Lagakos, J. H. Ware, Deborah L. Hunter, J. Drazen. Statistics in medicine--reporting of subgroup analyses in clinical trials. New England Journal of Medicine. 2007. 357: 2189-94.

Citation

Habib O. Ramadhani, Nathan Thielman, Keren Z. Landman, Evaline M. Ndosi, Feng Gao, Jennifer L. Kirchherr, Rekha Shah, Humphrey J. Shao, Susan C. Morpeth, Jonathan D. McNeill, John F. Shao, John Alexander Bartlett, John A. Crump. Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania. Clinical Infectious Diseases. 2007. 45: 1492-8.

Citation

Erik George, Francine Noel, Rose May Gyrlande Bois, Rachelle Cassagnol, Louise Estavien, Patricia De Matteis Rouzier, Rose I. Verdier, Warren D. Johnson, Jean William Pape, Daniel W. Fitzgerald, Peter Farnum Wright. Antiretroviral therapy for HIV-1-infected children in Haiti. Journal of Infectious Diseases. 2007. 195: 1411-8.

Citation

Nicholas T. Funderburg, Michael M. Lederman, Zhimin Feng, Michael G. Drage, Julie Jadlowsky, Clifford V. Harding, Scott F. Sieg. Human b-defensin-3 activates professional antigen-presenting cells via toll-like receptors 1 and 2. Proceedings of the National Academy of Sciences of the United States of America. 2007. 104: 18631-5.

Citation

Edward R. Cachay, Niousha Moini, Sergei L. Kosakovsky Pond, Rick L. Pesano, Yolanda Lie, Heidi Aiem, David M. Butler, Scott L. Letendre, W. Christopher Mathews, Davey M. Smith. Active methamphetamine use is associated with transmitted drug resistance to non-nucleoside reverse transcriptase inhibitors in individuals with HIV infection of unknown duration. The Open AIDS Journal. 2007. 1: 5-10.

Citation

Susan L Rosenkranz, Kevin E. Yarasheski, Michael F. Para, Richard C. Reichman, Gene D. Morse. Antiretroviral drug levels and interactions affect lipid, lipoprotein and glucose metabolism in HIV-1 seronegative subjects: A pharmacokinetic-pharmacodynamic analysis. Metabolic Syndrome and Related Disorders. 2007. 5: 163-73.